Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens (IOL) compared to the ZEISS AT LISA®* tri 839MP IOL.
Novartis released its Q3 financials and, despite Gleevec dipping significantly due to generic competition, still managed to report sales of $12.4 billion, up 2% on the previous year’s results.
Aerie Pharmaceuticals has yet again looked to Novartis’ struggling eye care unit for a new hire. Eric Carlson, Ph.D., has become the latest in a string of former Alcon employees to land at the smaller eye disease specialist.